- Home
- XFOR vs DTI Comparison
XFOR vs DTI Comparison
Compare XFOR & DTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XFOR
- DTI
- Stock Information
- Founded
- XFOR 2014
- DTI 1984
- Country
- XFOR United States
- DTI United States
- Employees
- XFOR N/A
- DTI N/A
- Industry
- XFOR Biotechnology: Biological Products (No Diagnostic Substances)
- DTI Metal Fabrications
- Sector
- XFOR Health Care
- DTI Industrials
- Exchange
- XFOR Nasdaq
- DTI Nasdaq
- Market Cap
- XFOR 84.3M
- DTI 82.6M
- IPO Year
- XFOR N/A
- DTI N/A
- Fundamental
- Price
- XFOR $3.80
- DTI $2.23
- Analyst Decision
- XFOR Strong Buy
- DTI Strong Buy
- Analyst Count
- XFOR 3
- DTI 1
- Target Price
- XFOR $34.17
- DTI $5.50
- AVG Volume (30 Days)
- XFOR 1.5M
- DTI 43.2K
- Earning Date
- XFOR 11-12-2025
- DTI 11-06-2025
- Dividend Yield
- XFOR N/A
- DTI N/A
- EPS Growth
- XFOR N/A
- DTI N/A
- EPS
- XFOR N/A
- DTI N/A
- Revenue
- XFOR $32,774,000.00
- DTI $162,240,000.00
- Revenue This Year
- XFOR $1,307.51
- DTI $0.13
- Revenue Next Year
- XFOR N/A
- DTI $1.58
- P/E Ratio
- XFOR N/A
- DTI N/A
- Revenue Growth
- XFOR 5721.31
- DTI 9.74
- 52 Week Low
- XFOR $1.35
- DTI $1.43
- 52 Week High
- XFOR $26.83
- DTI $3.82
- Technical
- Relative Strength Index (RSI)
- XFOR 62.57
- DTI 49.86
- Support Level
- XFOR $2.96
- DTI $2.15
- Resistance Level
- XFOR $4.54
- DTI $2.55
- Average True Range (ATR)
- XFOR 0.26
- DTI 0.15
- MACD
- XFOR 0.08
- DTI 0.01
- Stochastic Oscillator
- XFOR 57.47
- DTI 41.96
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About DTI Drilling Tools International Corporation
Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.